Burden of Antipsychotic-induced Parkinsonism: A Case Report
Authors
Department of Mental Health, Afe Babalola University, Ado-Ekiti, Ekiti (Nigeria)
Department of Behavioural Sciences, University of Ilorin Teaching Hospital, Ilorin (Nigeria)
Department of Behavioural Sciences, University of Ilorin Teaching Hospital, Ilorin (Nigeria)
Faculty of Clinical Sciences, University of Ilorin, Ilorin (Nigeria)
Ekiti State University Teaching Hospital, Ado-Ekiti (Nigeria)
Article Information
DOI: 10.51244/IJRSI.2026.1315PH00008
Subject Category: Mental Health
Volume/Issue: 13/15 | Page No: 1247-1250
Publication Timeline
Submitted: 2025-12-29
Accepted: 2026-01-04
Published: 2026-01-15
Abstract
Background
A wide range of side effects have been reported since the discovery of antipsychotics, amongst which are the extrapyramidal side effects that occur as a result of excessive blockade of D2 receptors in the brain.
Parkinsonism resulting from use of antipsychotics or other psychotropic medications characteristically presents with rigidity, bradykinesia and tremors, and this has significantly added to the burden of illness in patients and worsened burden of care in caregivers.
Case presentation
We present the case of a 29year old man who was previously managed with first generation antipsychotics for a psychotic disorder at a peripheral centre but left on high dose of the medication after remission. He presented at our facility with severe features of drug-induced parkinsonism without symptoms of psychosis. He was managed on admission for four weeks and only became free of features of parkinsonism after six weeks of treatment with anticholinergic medication.
Conclusion
Asides from the burden of primary illness, antipsychotic-induced parkinsonism causes additional distress and impairment to patients as it was with the reported case. However, adequate anticipation and management of attendant EPSE is very crucial in reducing this additional morbidity and burden associated with managing patients with neuro-psychiatric disorders.
Keywords
drug-induced parkinsonism, extrapyramidal side effects, burden of psychiatric illness
Downloads
References
1. Ali, T., Sisay, M., Tariku, M., Mekuria, A.N., & Desalew, A. (2021). Antipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studies. PLoS One, 16(9):e0257129. [Google Scholar] [Crossref]
2. Bolu, A., Garip, B., Öznur, T., & Uzun, Ö. (2019). Case of risperidone-induced tardive parkinsonism. Psychiatry Clin. Neurosci, 73: 285-286. [Google Scholar] [Crossref]
3. de Germay, S., Montastruc, F., Carvajal, A., Lapeyre-Mestre, M., & Monstastruc JL. (2020). Druginduced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database. Parkinsonism Relat Disord, 70: 55-59. [Google Scholar] [Crossref]
4. D'Souza, R.S., & Hooten, W.M. (2022). Extrapyramidal Symptoms. In StatPearls. StatPearls Publishing. [Google Scholar] [Crossref]
5. Femi, O.L., Ibrahim, A., & Aliyu, S. (2012) Clinical profile of parkinsonian disorders in the tropics: Experience at Kano, north-western Nigeria. J Neurosci Rural Pract, 3(3):237-241. doi:10.4103/09763147.102589. [Google Scholar] [Crossref]
6. Kumsa, A., Aganagnew, L., Alemu, B., & Girma S. (2020). Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatric Clinic. PLos ONE, 15(7). [Google Scholar] [Crossref]
7. Read J, Williams J. Positive and Negative Effects of Antipsychotic Medication: An International Online Survey of 832 Recipients. Curr Drug Saf, 14(3):173-181. [Google Scholar] [Crossref]
8. Skokou, M., Tsermpini, E., Giamarelou, A., Gogos, A., & Gourzis P. (2018). Tardive Dystonia due to D2 Antagonists and Other Agents. In Rizk, T. M. G, editor. London: Intech Open. [cited 2022 Oct 17]. Available from: https://www.intechopen.com/chapters/62437 doi: 10.5772/intechopen.78760. [Google Scholar] [Crossref]
9. Stroup, T. S., & Gray, N. (2018). Management of common adverse effects of antipsychotic medications. World psychiatry: official journal of the World Psychiatric Association (WPA), 17(3), 341–356. https://doi.org/10.1002/wps.20567. [Google Scholar] [Crossref]
10. Ugoya, S.O., Agaba, E.I., & Daniyam, C.A. (2011). Parkinsonism caused by adverse drug reactions: a case series. J Med Case Rep, 5:105. doi:10.1186/1752-1947-5-105. [Google Scholar] [Crossref]
11. Ward, K.M., & Citrome, L. (2018). Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management. Neurol Ther. 2018;7(2):233-248. [Google Scholar] [Crossref]
12. Wubeshet, Y.S., Mohammed, O.S., & Desse, T.A. (2019). Prevalence and management practice of first generation antipsychotics induced side effects among schizophrenic patients at Amanuel Mental Specialized Hospital, central Ethiopia: cross-sectional study. BMC Psychiatry, 19(1):32. [Google Scholar] [Crossref]
Metrics
Views & Downloads
Similar Articles
- Marital Adjustment and Its Relationship with Stress, Mental Health, Expectation, and Body Image
- Global and Malaysian Perspectives on Mental Health and Digital Interventions (2020–2025): A Narrative Review
- Mental Health in Cameroon: The Challenge of Treating Trauma. Case Study of Treatment Using the EMDR Protocol
- Reliability and Validity Assessment of a Psychological Adaptation Measurement Tool for College Students